Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression (Q37270469)

19 August 2017

1 reference

title

Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression (English)

1 reference

19 August 2017

0 references

Esma S Yolcu

1

1 reference

19 August 2017

Shifra Ash

2

1 reference

19 August 2017

Ayelet Kaminitz

3

1 reference

19 August 2017

Yuval Sagiv

4

1 reference

19 August 2017

Nadir Askenasy

5

1 reference

19 August 2017

Shai Yarkoni

6

1 reference

19 August 2017

publication date

16 September 2008

1 reference

Immunology & Cell Biology

19 August 2017

published in

1 reference

19 August 2017

volume

86

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

650-658

1 reference

Regulatory T cells in autoimmmunity*.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Natural versus adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+ Tregs and immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cells and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cells in immunologic self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Natural regulatory T cells and self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Development and function of CD25+CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Signalling pathways of the TNF superfamily: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The signaling adaptors and pathways activated by TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The role of Fas ligand in immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Fas ligand as a tool for immunosuppression and generation of immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Induction of tolerance using Fas ligand: a double-edged immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Fas transduces activation signals in normal human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Caspase activation is required for T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulated commitment of TNF receptor signaling: a molecular switch for death or activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Tumor necrosis factor receptor and Fas signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Death receptors couple to both cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Peripheral deletion of antigen-reactive T cells in oral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Naive CD4(+) lymphocytes convert to anergic or memory-like cells in T cell-deprived recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Interleukin-2 is essential for CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cells are resistant to apoptosis via TCR but not P2X7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Dichotomy between naïve and memory CD4(+) T cell responses to Fas engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Differential ability of T cell subsets to undergo activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Mechanisms of T regulatory cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The greater chemotactic network for lymphocyte trafficking: chemokines and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T-cell compartmentalization and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Naturally occurring regulatory T cells: recent insights in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Where CD4+CD25+ T reg cells impinge on autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Tolerance, not immunity, crucially depends on IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

IL-2, regulatory T cells, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The dichotomous role of IL-2: tolerance versus immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Lymphokine regulation of activation-induced apoptosis in T cells of IL-2 and IL-2R beta knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The control of CD4+CD25+Foxp3+ regulatory T cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Tolerance induction by third-party "off-the-shelf" CD4+CD25+ Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Fas and Fas ligand: lpr and gld mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Combining Fas mutation with interleukin-2 deficiency prevents Colitis and Lupus: implicating interleukin-2 for auto-reactive T cell expansion and Fas ligand for colon epithelial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

The role of Fas in the immune system biology of IL-2R alpha knockout mice: interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+CD25+ T Cells Lyse Antigen-Presenting B Cells by Fas-Fas Ligand Interaction in an Epitope-Specific Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Gene- and cell-based therapeutics for type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

CD4+ CD25+ suppressor T cells: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Human CD4+CD25+ regulatory T cells suppress anti-porcine xenogeneic responses

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

From vanilla to 28 flavors: multiple varieties of T regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Fas ligand costimulates the in vivo proliferation of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

The CD95 Receptor: Apoptosis Revisited

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Tracing the action of IL-2 in tolerance to islet-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

The effect of TGF-beta1 on immune responses of naïve versus memory CD4+ Th1/Th2 T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Regulation of TGF-beta response during T cell activation is modulated by IL-10

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.62

7 January 2021

Identifiers

DOI

10.1038/ICB.2008.62

1 reference

19 August 2017

1 reference